Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
Disease Category: Ovarian Cancer
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

Ovarian, Fallopian Tube or Peritoneal Cancer

Purpose

Winthrop University Hospital Gynecologic Oncology Department is seeking volunteers who have been diagnosed with Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer and are willing to participate in a clinical research study to see if an investigational vaccine is safe and effective. Eligible participants will receive the study-related vaccine and study-related medical care at no cost to them.

Patient Inclusion Criteria:

  • Subjects with stage II-IV ovarian, fallopian tube or peritoneal cancer who have completed treatment consisting of up to 8 cycles of chemotherapy or other acceptable chemotherapy after initial surgery.
  • Subjects with recurrent ovarian, fallopian tubal or peritoneal cancer

To Learn more
Phase

1/2

Gender

Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

Jennifer Brown, RN
Winthrop University Hospital Clinical Trials Center
222 Station Plaza North
Suite 300
Mineola, NY 11501
Phone: 516-663-9582
Fax: 516-663-9587

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 180820

Date Last Changed: July 19, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.